Clinical Trial of Approaches to Prostate Cancer Surgery
Clinical TrIAL of Approaches to Prostate cAncer suRgery
Weill Medical College of Cornell University
600 participants
May 15, 2023
INTERVENTIONAL
Conditions
Summary
This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy. The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.
Eligibility
Inclusion Criteria5
- Male sex
- Age ≥40 years or ≤80 years
- Scheduled for radical prostatectomy for clinically localized prostate cancer
- Able to read and speak English or Spanish
- Willingness to sign informed consent and adhere to the study protocol
Exclusion Criteria2
- Prior major pelvic surgery or radiotherapy
- Suspicion of N1 disease (i.e., any lymph node greater than 1cm in maximal diameter)
Interventions
The conventional approach to prostate cancer surgery
A novel, posterior approach to radical prostatectomy that preserves the dorsal vascular complex, nerves and fascial support structures that overlie the anterior prostate.
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05155501